Increasing incidence of Cardiovascular Diseases worldwide is creating growth opportunities for the Global Cardiovascular Stents Market, predicts Fortune Business Insights in their new study. The study is titled “Cardiovascular Stents Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025”. As per Fortune Business Insights, the market is prognosticated to exhibit 6.6% CAGR and reach a valuation of US$ 13,100.2 Mn by 2025 from US$ 7,838.9 Mn in 2017.
Some of the leading companies in the global Cardiovascular Stents Market are
- Biotronik SE & Co. KG
- Cardinal Health
- R. Bard, Inc.
- MicroPort Scientific Corporation
- Terumo Corporation
- Braun Melsungen AG
- Boston Scientific Corporation
Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/cardiovascular-stents-market-100061
Increasing Number of Cardiovascular Cases to Fuel Demand in Market
Unhealthy lifestyle and irregular eating habits of people have led to having increased the prevalence of health-related concerns, including chronic diseases such as diabetes, obesity, and heart disorders. The surging cases of heart disorder are continuously fueling the demand for treating heart problems including angioplasty, which ultimately increased the demand for cardiovascular stents.
However, the market may face challenges due to the presence of alternative treatment methods for vascular diseases. Again, the complexity of cardiovascular stent implantation may cause patients to opt for other treatment options and this may restrict growth in the market. Besides this, the incident of product recalls and failures may also hamper the market in the future.
Key Segments Analysis:
By Product Type
- Coronary Stenting
- Peripheral Stenting
By Stent Type
- Drug Eluting Stents (DES)
- Bioresorbable Stents
- Bare Metal Stents
By Disease Indication
- Venous Disease
- Arterial Disease
By End User
- Ambulatory Surgery Centers
- Specialty Clinics
- Catheterization Labs
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Alpine Stent to Open Growth Opportunities for Market in the Asia Pacific
The market for cardiovascular stents in the Asia Pacific is likely to show growth at a higher rate on account of the improved distribution of cardiovascular stents in emerging economies such as China and India. In order to improve their accessibility, price capping of stents is introduced in these developing nations and this will help the market gain momentum. Thus, Asia Pacific is likely to register itself as the fastest growing region in the during the forecast tenure.
The cardiovascular stents market in North America was emerged dominant and was valued at US$ 2,344.9 Mn in 2017. This is mainly due to the presence of better medical facilities and skilled professionals in the developed nations of Canada and the U.S. North America is likely to remain dominant in the coming years as well on account of ongoing clinical trials on novel stents in the U.S. and various regulatory approvals on cardiovascular stents.
Various companies operating in the global cardiovascular stents market are B. Braun Melsungen AG, Cardinal Health, C. R. Bard, Inc., Terumo Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, and others. Major vendors are focusing on investing in clinical studies and research and development of better stents. At present, Boston Scientific Corporation, Abbott, and Medtronic are leading the market.
More Trending Topics from Fortune Business Insights: